]>
IRCT20180108038262N2 IRCT 2018-08-10 Tehran University of Medical Sciences The use of vitamin D supplementation and risk of hypercalciuria evaluation of effect of Vitamin D supplementation on hypercalciuria in vitamin D deficient recurrent stone former patients 2014-01-01 anticipated 30 Complete https://irct.ir/trial/33097 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. N/A Condition 1: urolithiasis. Condition 2: vitamin D deficiency. Intervention group: administration of vitamin D pearl 50000 unit weekly for 2 month and then every 2 weak until third month. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Mohammad Reza Ganji
Shariati Hospital, Jalal Ale Ahmad Ave, North Karegar St, Tehran, Iran
Tehran Iran (Islamic Republic of) 1411713135 +98 21 8490 1000 mrezaganji@yahoo.com Tehran University of Medical Sciences scientific Mohammad Reza Ganji
Shariati Hospital, Jalal Ale Ahmad Ave, North Karegar St, Tehran, Iran
Tehran Iran (Islamic Republic of) 1411713135 +98 21 8490 1000 mrezaganji@yahoo.com Tehran University of Medical Sciences Iran (Islamic Republic of) urinary stone former vitamin D defficiency sign the constant form 20 years 65 years Both pregnant patients hypercalcemia (baseline calcium level of ≥10.4 mg/dl) medications that affect calcium and bone metabolism (such as calcium) or calcium excretion (such as steroidal or hormonal drugs), previous history of primary hyperparathyroidism or other systemic diseases (cancer, alcoholic liver disease and osteoporosis) patients who had invasive diagnostic or therapeutic interventions on renal stones within the last month prior to enrollment known case of uric acid ,cysteine or steruvite urinary stone N20 E55.9 Calculus of kidney and ureter Vitamin D deficiency, unspecified Treatment - Drugs Intervention group: administration of vitamin D pearl 50000 unit weekly for 2 month and then every 2 weak until third month Amount of increase in urinary calcium. Timepoint: before and after 3 month of vitamin D prescription. Method of measurement: measurement of calcium in 24 hour urine. Urinary stone formation. Timepoint: 3 month after treatment. Method of measurement: ultrasound examination. Serum parathyroid change. Timepoint: before and 3 month after vitamin D prescription. Method of measurement: laboratory measurment. Tehran University of Medical Sciences Approved 2013-12-22 Tehran University Of Medical Science Ethics Committee Ghods Street,Keshavarz Blvd, Central Organization of University of Medical Science, 6th floor Tehran Tehran Iran (Islamic Republic of)